Drug recall · March 13, 2019
Tamsulosin Hydrochloride Capsules recall
Why: Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.
- Lots / codes
Lot #: 8144652, Exp Jul 2020
- Quantity
- 3,072 bottles
- Company
- Ascend Laboratories LLC, Parsippany, NJ
- Distribution
- Nationwide in the USA and Puerto Rico.
- Initiated
- February 22, 2019 · Voluntary: Firm initiated
- Classified
- March 29, 2019
- Reported
- March 13, 2019
- Ended
- March 18, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tamsulosin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.